Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Primary Progressive MS
NCT00950248Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2009
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idebenone in primary progressive multiple sclerosis (PPMS), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2009; status: completed.
02
Drugs
idebenone
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT00950248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950248.